Open AccessFDA and Its Role in Drug Development
Author(s) -
Richard Pazdur
Publication year - 2021
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2021.12.3.15
Subject(s) - medicine , drug development , covid-19 , pandemic , drug approval , excellence , clinical trial , center of excellence , drug , oncology , intensive care medicine , pharmacology , virology , disease , outbreak , political science , infectious disease (medical specialty) , law
JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken place as a result of the COVID-19 pandemic.